LOS ANGELES, April 30 (UPI) -- An experimental therapy to freeze the molecular process that triggers allergic reactions is showing promise in animal studies and could be a potential treatment for humans, scientists reported Tuesday.
Advertisement
Advertisement |
LOS ANGELES, April 30 (UPI) -- An experimental therapy to freeze the molecular process that triggers allergic reactions is showing promise in animal studies and could be a potential treatment for humans, scientists reported Tuesday.